Mon, December 12, 2022
Fri, December 9, 2022
Thu, December 8, 2022
Wed, December 7, 2022
Tue, December 6, 2022
Mon, December 5, 2022
Sun, December 4, 2022
Fri, December 2, 2022
Thu, December 1, 2022

Terence Flynn Maintained (UTHR) at Buy with Increased Target to $330 on, Dec 6th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-330-on-dec-6th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Terence Flynn of Morgan Stanley, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $322 to $330 on, Dec 6th, 2022.

Terence has made no other calls on UTHR in the last 4 months.



There are 4 other peers that have a rating on UTHR. Out of the 4 peers that are also analyzing UTHR, 0 agree with Terence's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Terence


  • Chris Shibutani of "Goldman Sachs" Initiated at Strong Sell and Held Target at $230 on, Monday, December 5th, 2022
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $375 on, Thursday, November 3rd, 2022
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $265 on, Thursday, November 3rd, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $300 on, Thursday, November 3rd, 2022

Publication Contributing Sources